Leaderboards/diabetes cardiovascular risks and lipoproteins

diabetes cardiovascular risks and lipoproteins

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Stephen J. Nicholls
Monash University
99
2
John H. Krege
Eli Lilly (United States)
90
3
Herbert Tilg
Innsbruck Medical University
80
4
Giovanni Targher
University of Verona
70
5
Vincent Chen
University of Michigan
60
6
W. Ray Kim
WinnMed
50
7
Binyang Yu
Chinese Academy of Medical Sciences & Peking Union Medical College
40
8
Rui Gao
Chinese Academy of Medical Sciences & Peking Union Medical College
30
9
Liang Chen
Chinese Academy of Medical Sciences & Peking Union Medical College
20
10
Shengshou Hu
Chinese Academy of Medical Sciences & Peking Union Medical College
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jeanine E. Roeters van Lennep
Erasmus MC
99
2
Steven E. Nissen
Cleveland Clinic
90
3
Tian Wang
The University of Sydney
80
4
Xuan Wang
Tulane University
70
5
Glenn M. Chertow
Palo Alto University
60
6
Qianqian Min
Jinggangshan University
50
7
Omar Mhaimeed
Johns Hopkins Hospital
40
8
Nathan D. Wong
University of California, Irvine
30
9
Seema Mehdi
Columbia University
10

Emerging Leaders Papers

1
Inhibition of VEGFR-3 by SAR131675 decreases renal inflammation and lymphangiogenesis in the murine lupus nephritis model
Cell Death Discovery|2025
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Sidney C. Smith
American Heart Association
99
2
William B. Kannel
Framingham Heart Study
90
3
Nancy R. Cook
Harvard University
80
4
William P. Castelli
Framingham Heart Study
70
5
Emelia J. Benjamin
National Heart Lung and Blood Institute
60
6
Christopher J. O’Donnell
Framingham Heart Study
50
7
Hans Wedel
Sahlgrenska University Hospital
40
8
Christie M. Ballantyne
Houston Methodist
30
9
for the PRINCE Investigators
Unknown
20
10
Shujuan Yang
Sichuan University
20

All-Time Leaders Papers

1
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
New England Journal of Medicine|2002
3.6k cit.
2
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Circulation|2006
2.1k cit.
3
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Circulation|2011
1.8k cit.
4
Obesity and Systemic Oxidative Stress
Arteriosclerosis Thrombosis and Vascular Biology|2003
1.3k cit.
5
Blood Lipids and the Incidence of Atrial Fibrillation: The Multi‐Ethnic Study of Atherosclerosis and the Framingham Heart Study
Journal of the American Heart Association|2014
191 cit.

Indexing diabetes cardiovascular risks and lipoproteins Reagents

Citation data for reagents in this field is currently compiling.